Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study

British Journal of Haematology

Volumn 105, Issue 1, 1999, Pages 110-116

  Rumley, A ^a   Lowe, G D ^a   Sweetnam, P M ^b   Yarnell, J W G ^c   Ford, R P ^d  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b LLANDOUGH HOSPITAL   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d Shield Diagnostics Ltd   (United Kingdom)

Author keywords

Factor VIII; Ischaemic heart disease; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRIN FORMATION; HEART DEATH; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 0032942943     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1999.01317.x     Document Type: Article

References (24)

1. Badimon, L. & Fuster, V. (1992) von Willebrand factor and atherosclerotic cardiovascular disease. Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Functions (cd. by R. B. Francis), pp. 53-85. Marcel Dekker, New York.
2. Bainton, D., Miller. N.B., Bolton. C.H., Yarnell, J.W.G., Sweetnam, P.M., Baker, I.A., Lewis, B. & Ehvood. P.C. (1992) Plasma triglycéride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell collaborative heart disease studies. British Heart Journal. 68. 60-66.
3. Blann. A.D. & McCallum. C.N. (1994) von Willcbrand factor, endothelial cell damage and atherosclerosis. European Journal of Vascular Surgery, 8, 10-15.
4. Brinkhous, K.M., Reddick. R.L.-Read, M.S., Nichols, T.C., Bellinger, D.A. & Griggs, T.R. (1991) Von Willebrand factor and animal models: contributions to gene therapy, thrombotic thrombocytopenic purpura, and coronary artery thrombosis. Mayo Clinic Proceedings. 66, 733-742.
5. Cortellaro, M., Confrancesco, E. & Bochetti, C. (1993) Increased fibrin turnover and high PAI-1 activity as predictors of ischaemic events in atherosclerotic patients: a case-control study. Arteriosclerosis and Thrombosis. 13, 1412-1417.
6. Folsom. A.R., Wu, K.K., Rosamond, W.D., Sharrett, A.R. & ChamblessV L.E. (1997) Prospective study of hemostatic factors and incidence of coronary heart disease. The Atherosclerosis Risk in Communities (AR1C) Study. Circulation, 96, 1102-1108.
7. Jansson, J.H., Nilsson, T.K. & Johnson, O. (1991) von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. British Heart Journal, 66, 351-355.
8. Lowe, G.D.O. (1997) Haemostatic risk factors for arterial and venous thrombosis. Recent Advances in Blood Coagulation, 7, 69-96.
9. Meade, T.W., Cooper. J.A., Stirling, Y., Howarth. D.J., Ruddock. V. & Miller. G.J. (1994) Factor VIII, ABO blood group and the incidence of ischaemic heart disease. British Journal of Haematology, 88, 601-607.
10. Meade, T.W., Mellows, S., Brozovic, M., Miller. G.J., Chakrabarti. R.R., North. W.R.S., Haines, A.P., Stirling, Y., Imeson. J.D. & Thompson. S.G. (1986) Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet, ii, 533-537.
11. Meade, T.W., North. W.R.S., Chakrabarti, R., Haines, A.P. & Stirling, Y. (1977) Population-based distributions of haemostatic variables. British Medical Bulletin, 33, 283-288.
12. Meade. T.W., North, W.R.S., Chakrabarti, R.R., Stirling. Y., Haines, A.P. & Thompson, S.G. (1980) Haemostatic function and cardiovascular death: early results of a prospective study. lancet, I 1050-1054.
13. Murdock, P.J., Woodhams, B.J., Matthews, K.B., Pasi, K.J. & Goodall, A.H. (1997) Von Willebrand factor activity detected in a monoclonal antibody-based ELISA. Thrombosis and Hacmostasis, 78, 1272-1277.
14. O'Brien, J.R. (1990) Shear-induced platelet aggregation. Lancet, 335, 711-713.
15. Pottinger, B.E., Read, R.C., Paleolog, E.M., Higgins, P.G. & Pearson, J.D. (1989) von Willebrand factor is an acute phase reactant in man. Thrombosis Research, 53, 387-393.
16. Rose, G.A. (1962) The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bulletin of the World Health Organization, 27, 645-658.
17. Rosendaal, F.R., Varekamp, I., Smit, C., Brocker-Vriends, H.J.T., van Dijck. H., Vandenbroucke, J.P., Hermans, J., Suurmeijer, T.P.B.M. & Briet, E. (1989) Mortality and causes of death in Dutch haemophiliacs, 1973-86. British Journal of Haematology, 71, 71-76.
18. Smith, F.B., Lee, A.J., Fowkes, F.G.R., Price, J.F., Rumley, A. & Lowe, G.D.O. (1997) Hemostatic factors as predictors of ischémie heart disease and stroke in the Edinburgh Artery Study. Arteriosclerosis, Thrombosis and Vascular Biology. 17, 3321-3325.
19. Sweetnam, P.M., Thomas, U.E. Yarnell, J.W.G., Baker, I.A. & Ehvood, P.C. (1997) Total and differential leucocyte counts as predictors of ischémie heart disease: The Caerphilly and Speedwell Studies. American Journal of Epidemiology, 145. 416-421.
20. Thompson. S.G., Kienast. J. & Pyke, S.D.M. (1995) Haemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New England Journal of Medicine, 332, 635-641.
21. Tunstall-Pedoe, H., Kuulasmaa, K. & Amouyel, P. (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 90, 583-612.
22. Wilhelmsen, L., Svardsudd. K. & Korsan-Bengtsen. K. (1984) Fibrinogen as a risk factor for stroke and myocardial infarction. Ne\v England Journal of Medicine, 311, 501-505.
23. Woodburn, K.R., Rumley, A., Lowe, G.D.O., Love, J.G., Murray, G.D. & Pollock, J.G. (1996) Clinical, biochemical and rhéologie factors affecting the outcome of infrainguinal bypass grafting. Journal of Vascular Surgery, 24. 639-646.
24. Yarnell, J.W.G., Baker, I.A., Sweetnam, P.M., Bainton, D., O'Brien, J.R., Whitehead, P.J. & Elwood, P.C. (1991) Fibrinogen, viscosity, and white blood cell count are major risk factors for ischémie heart disease. Circulation, 83, 836-844.